comparemela.com

Latest Breaking News On - Structured monitoring - Page 1 : comparemela.com

Zomedica Reports Record Revenue of $7 3 Million for the Fourth Quarter and $25 2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100 5 Million in Liquidity

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for

United statesAnn arborLarry heatonMonitoring products incZomedica corpCompany global manufacturing distribution centers in roswellQorvo biotechnologiesTherapeutic devicesZomedica chief executive officerStructured monitoring productsZero touch vital signs remote monitoringCash equivalentsAvailable for sale securitiesSenior vice presidentGlobal manufacturingDistribution centers

Zomedica Reports Record Revenue of $7 3 Million for the Fourth Quarter and $25 2 Million for the Ful

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for equine and companion animals, today reported consolidated financial results for the four.

United statesAnn arborLarry heatonMonitoring products incQorvo biotechnologiesCompany global manufacturing distribution centers in roswellZomedica corpTherapeutic devicesZomedica chief executive officerStructured monitoring productsZero touch vital signs remote monitoringCash equivalentsAvailable for sale securitiesSenior vice presidentGlobal manufacturingDistribution centers

Zomedica Reports Record Revenue of $7 3 Million for the Fourth Quarter and $25 2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100 5 Million in Liquidity

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for

United statesAnn arborLarry heatonMonitoring products incCompany global manufacturing distribution centers in roswellQorvo biotechnologiesZomedica corpTherapeutic devicesZomedica chief executive officerStructured monitoring productsZero touch vital signs remote monitoringCash equivalentsAvailable for sale securitiesSenior vice presidentGlobal manufacturingDistribution centers

Zomedica Reports Record Revenue of $7 3 Million for the Fourth Quarter and $25 2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100 5 Million in Liquidity

ANN ARBOR, MI / ACCESSWIRE / April 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device products for

United statesAnn arborLarry heatonCompany global manufacturing distribution centers in roswellZomedica corpQorvo biotechnologiesMonitoring products incTherapeutic devicesZomedica chief executive officerStructured monitoring productsZero touch vital signs remote monitoringCash equivalentsAvailable for sale securitiesSenior vice presidentGlobal manufacturingDistribution centers

Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6 3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies

ANN ARBOR, MI / ACCESSWIRE / November 13, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion

United statesAnn arborLarry heatonQorvo biotechnologiesExchange commission onPathology departmentMonitoring products incZomedica corpQuarter financialTherapeutic devicesStructured monitoringStructured monitoring productsCurrent reportExchange commissionCompany guideQuarter results

vimarsana © 2020. All Rights Reserved.